The nation of Zimbabwe has rejected a significant American healthcare agreement worth 367 million US dollars (£272m) over five years due to the United States' insistence on confidential information.
The decision was revealed after a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official spokesperson later clarified that the United States was seeking genetic material for scientific study and profit but was not willing to guarantee the resulting advantages from future medical innovations.
"We are forced to start the difficult and regrettable process of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for further dialogue to reach a agreement agreeable to both sides so the country's critical HIV programme can continue.
Broader Background
This development follows a comparable case in neighbouring Kenya, where a high court halted a related deal with the US following legal challenges were filed about the security of Kenyans' health data.
Since resuming office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump stated its spending was "inefficient" and his government was pursuing direct bilateral deals to enhance openness and accountability.
Based on statements, 16 nations in Africa have to date signed these new health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Declined Deal
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment through US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any corresponding assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"In essence, our nation would provide the basic resources for medical research with no assurance that the end products would be accessible to our population should a new health crisis emerge."
National Interest and International Frameworks
He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were disrupting systems already set up via the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to manage future global health emergencies.
"This system is designed to ensure that when a nation contributes its samples, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We encourage further discussions with our American counterparts on how future co-operation might be designed in a way that respects the sovereignty and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but suggested that negotiations should continue considering a large portion of the nation's HIV programmes depended on foreign aid.
"If technical issues exist, including those relating to data governance or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," the group added.
This impasse highlights the ongoing challenges between accepting crucial foreign assistance and protecting a country's data in an ever more interconnected world.